Stocktoria
Kyverna Therapeutics, Inc. KYTX
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2024-02-08
Kyverna Therapeutics, Inc. institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| BlackRock Finance, Inc. | 1,453,667 | $10.9M |
| MILLENNIUM MANAGEMENT LLC | 1,005,508 | $8.7M |
| D. E. Shaw & Co., Inc. | 721,581 | $6.2M |
| RENAISSANCE TECHNOLOGIES LLC | 367,492 | $3.2M |
| Point72 Asset Management, L.P. | 222,929 | $1.9M |
| TWO SIGMA INVESTMENTS, LP | 181,615 | $1.6M |
| CITADEL ADVISORS LLC | 87,626 | $756,212 |
Source: SEC EDGAR filings · CIK 0001994702 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.